Eli Lilly and Company (NYSE:LLY) is included among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors. On June 23, Reuters reported that Eli Lilly and Company (NYSE:LLY) expects to launch ...

Eli Lilly (LLY) has bought the pain therapy developer 4E Therapeutics, the Austin-based neuroscience company announced on Tuesday, marking the weight loss drugmaker’s latest acquisition. 4E is a ...

Eli Lilly and Company (NYSE:LLY) rose around 12% in May 2026, primarily driven by strong FQ1 2026 earnings beat and FDA approval for Foundayo and expansion of insurance coverage of obesity treatment.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Retatrutide's 19% weight loss data pushed LLY to a 52-week high, and four straight EPS beats make the $1,500 optimistic target achievable. AZN's elecoglipron delivered only 12% weight loss in Phase 3 ...

Swedish biotech AlzeCure Pharma announced on Tuesday a collaboration and a licensing agreement with Eli Lilly (LLY) to develop an Alzheimer’s therapy as part of a deal that could potentially exceed ...